Optiver Holding
COLL icon

Optiver Holding’s Collegium Pharmaceutical COLL Stock Holding History

Optiver Holding’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43K Buy
+150
New +$5.13K ﹤0.01% 1952
2025
Q4 		– Sell
-130
Closed -$4.55K – 2569
2025
Q3 		$4.55K Buy
+130
New +$4.52K ﹤0.01% 1820

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Optiver Holding's COLL Position: Q2 2026 in Review

Optiver Holding opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 150 shares worth $5.43K. The stake represents ﹤0.01% of the portfolio and ranks #1952 among its holdings. This is a return to the name: Optiver Holding previously reported a position in COLL as recently as Q3 2025.

Optiver Holding first reported a position in COLL in Q3 2025 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Optiver Holding held 150 shares of Collegium Pharmaceutical worth $5.43K as of Q2 2026.
  • Collegium Pharmaceutical was a new Optiver Holding position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1952 holding.
  • Optiver Holding first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.